Esprit Pharma News
Most Popular Esprit Pharma Story
Allergan injects $370M into Esprit buyout
Allergan is taking some of the money it makes from Botox to buy Esprit Pharma for $370 million in cash. New Jersey-based Esprit makes Sanctura for overactive bladder and is launching Sanctura XR. Read more...
Latest Headlines
- September 19, 2007
- December 17, 2006
- August 9, 2006
- August 1, 2006
- May 24, 2006
- May 16, 2006
- September 28, 2005
- September 7, 2005
- July 27, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
